Annual Total Long Term Liabilities
$71.25 M
-$27.98 M-28.20%
December 31, 2022
Summary
- As of February 10, 2025, IMGN annual total long term liabilities is $71.25 million, with the most recent change of -$27.98 million (-28.20%) on December 31, 2022.
- During the last 3 years, IMGN annual total long term liabilities has fallen by -$162.72 million (-69.55%).
Performance
IMGN Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$125.84 M
-$3.94 M-3.03%
September 30, 2023
Summary
- As of February 10, 2025, IMGN quarterly total long term liabilities is $125.84 million, with the most recent change of -$3.94 million (-3.03%) on September 30, 2023.
- Over the past year, IMGN quarterly long term liabilities has increased by +$48.70 million (+63.12%).
Performance
IMGN Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
IMGN Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -28.2% | +63.1% |
3 y3 years | -69.5% | -34.1% |
5 y5 years | -72.3% | -43.5% |
IMGN Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -28.2% | at low | -3.0% | -48.5% |
5 y | 5-year | -69.5% | at low | -46.2% | -48.5% |
alltime | all time | -76.3% | -99.9% | -58.2% | -100.0% |
ImmunoGen Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2023 | - | $125.84 M(-3.0%) |
Jun 2023 | - | $129.78 M(+100.3%) |
Mar 2023 | - | $64.80 M(-9.1%) |
Dec 2022 | $71.25 M(-28.2%) | $71.25 M(-7.6%) |
Sep 2022 | - | $77.15 M(-9.7%) |
Jun 2022 | - | $85.39 M(-6.3%) |
Mar 2022 | - | $91.12 M(-8.2%) |
Dec 2021 | $99.23 M(-30.7%) | $99.23 M(-8.1%) |
Sep 2021 | - | $107.92 M(-4.2%) |
Jun 2021 | - | $112.66 M(-4.1%) |
Mar 2021 | - | $117.49 M(-17.9%) |
Dec 2020 | $143.18 M(-38.8%) | $143.18 M(-25.0%) |
Sep 2020 | - | $191.02 M(-6.1%) |
Jun 2020 | - | $203.37 M(-6.5%) |
Mar 2020 | - | $217.41 M(-7.1%) |
Dec 2019 | $233.97 M(+9.5%) | $233.97 M(-7.2%) |
Sep 2019 | - | $252.19 M(-10.3%) |
Jun 2019 | - | $281.23 M(-3.1%) |
Mar 2019 | - | $290.10 M(+35.7%) |
Dec 2018 | $213.75 M(-16.8%) | $213.75 M(-4.0%) |
Sep 2018 | - | $222.61 M(-2.6%) |
Jun 2018 | - | $228.55 M(-2.8%) |
Mar 2018 | - | $235.05 M(-8.5%) |
Dec 2017 | $256.80 M(-13.2%) | $256.80 M(-2.5%) |
Sep 2017 | - | $263.33 M(-8.3%) |
Jun 2017 | - | $287.26 M(-1.1%) |
Mar 2017 | - | $290.48 M(-2.4%) |
Dec 2016 | $295.94 M(-1.7%) | - |
Sep 2016 | - | $297.66 M(-1.1%) |
Jun 2016 | $301.11 M(+26.3%) | $301.11 M(+34.6%) |
Mar 2016 | - | $223.66 M(-0.3%) |
Dec 2015 | - | $224.37 M(-5.7%) |
Sep 2015 | - | $238.03 M(-0.2%) |
Jun 2015 | $238.49 M(+248.9%) | $238.49 M(+364.7%) |
Mar 2015 | - | $51.32 M(+63.3%) |
Dec 2014 | - | $31.43 M(-29.2%) |
Sep 2014 | - | $44.36 M(-35.1%) |
Jun 2014 | $68.36 M(-5.8%) | $68.36 M(+1.2%) |
Mar 2014 | - | $67.56 M(+23.2%) |
Dec 2013 | - | $54.85 M(-14.3%) |
Sep 2013 | - | $64.04 M(-11.8%) |
Jun 2013 | $72.58 M(-9.5%) | $72.58 M(-0.4%) |
Mar 2013 | - | $72.87 M(-9.2%) |
Dec 2012 | - | $80.21 M(+0.4%) |
Sep 2012 | - | $79.93 M(-0.3%) |
Jun 2012 | $80.16 M(+27.0%) | $80.16 M(-0.5%) |
Mar 2012 | - | $80.60 M(-0.8%) |
Dec 2011 | - | $81.25 M(+30.8%) |
Sep 2011 | - | $62.11 M(-1.6%) |
Jun 2011 | $63.11 M(+195.7%) | $63.11 M(-1.6%) |
Mar 2011 | - | $64.13 M(-1.2%) |
Dec 2010 | - | $64.89 M(+216.0%) |
Sep 2010 | - | $20.53 M(-3.8%) |
Jun 2010 | $21.34 M(-6.1%) | $21.34 M(-2.5%) |
Mar 2010 | - | $21.87 M(-3.4%) |
Dec 2009 | - | $22.64 M(+0.1%) |
Sep 2009 | - | $22.63 M(-0.4%) |
Jun 2009 | $22.72 M(+28.7%) | $22.72 M(-4.5%) |
Mar 2009 | - | $23.78 M(-2.6%) |
Dec 2008 | - | $24.40 M(+16.7%) |
Sep 2008 | - | $20.91 M(+18.4%) |
Jun 2008 | $17.65 M(+128.3%) | $17.65 M(-8.6%) |
Mar 2008 | - | $19.32 M(+45.5%) |
Dec 2007 | - | $13.27 M(+58.5%) |
Sep 2007 | - | $8.37 M(+8.3%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2007 | $7.73 M(-30.1%) | $7.73 M(-11.5%) |
Mar 2007 | - | $8.73 M(-12.7%) |
Dec 2006 | - | $10.00 M(-6.2%) |
Sep 2006 | - | $10.67 M(-3.5%) |
Jun 2006 | $11.05 M(-21.4%) | $11.05 M(-5.9%) |
Mar 2006 | - | $11.74 M(-12.1%) |
Dec 2005 | - | $13.35 M(-3.6%) |
Sep 2005 | - | $13.85 M(-1.5%) |
Jun 2005 | $14.06 M(-1.0%) | $14.06 M(+8.0%) |
Mar 2005 | - | $13.03 M(-8.1%) |
Dec 2004 | - | $14.17 M(+7.2%) |
Sep 2004 | - | $13.22 M(-6.9%) |
Jun 2004 | $14.21 M(+48.9%) | $14.21 M(-6.4%) |
Mar 2004 | - | $15.18 M(-5.4%) |
Dec 2003 | - | $16.04 M(-13.5%) |
Sep 2003 | - | $18.54 M(+94.3%) |
Jun 2003 | $9.54 M(-16.6%) | $9.54 M(-3.9%) |
Mar 2003 | - | $9.93 M(-4.0%) |
Dec 2002 | - | $10.34 M(-5.8%) |
Sep 2002 | - | $10.98 M(-4.0%) |
Jun 2002 | $11.44 M(+0.7%) | $11.44 M(-3.3%) |
Mar 2002 | - | $11.83 M(+3.3%) |
Dec 2001 | - | $11.45 M(+4.4%) |
Sep 2001 | - | $10.97 M(-3.4%) |
Jun 2001 | $11.35 M(+652.8%) | $11.35 M(+41.9%) |
Mar 2001 | - | $8.00 M(+33.3%) |
Dec 2000 | - | $6.00 M(+42.7%) |
Sep 2000 | - | $4.21 M(+178.9%) |
Jun 2000 | $1.51 M(+1408.1%) | $1.51 M(+7329.1%) |
Mar 2000 | - | $20.30 K(-79.7%) |
Sep 1999 | - | $100.00 K(0.0%) |
Jun 1999 | $100.00 K(0.0%) | $100.00 K(0.0%) |
Mar 1999 | - | $100.00 K(0.0%) |
Jun 1998 | $100.00 K(0.0%) | $100.00 K(0.0%) |
Mar 1998 | - | $100.00 K(>+9900.0%) |
Sep 1997 | - | $0.00(-100.0%) |
Jun 1997 | $100.00 K(-97.4%) | $100.00 K(0.0%) |
Mar 1997 | - | $100.00 K(-96.0%) |
Sep 1996 | - | $2.50 M(-35.9%) |
Jun 1996 | $3.90 M(+62.5%) | $3.90 M(+56.0%) |
Mar 1996 | - | $2.50 M(+2400.0%) |
Dec 1995 | - | $100.00 K(-95.8%) |
Sep 1995 | - | $2.40 M(0.0%) |
Jun 1995 | $2.40 M(-31.4%) | $2.40 M(-11.1%) |
Mar 1995 | - | $2.70 M(-18.2%) |
Sep 1994 | - | $3.30 M(-5.7%) |
Jun 1994 | $3.50 M(+169.2%) | $3.50 M(+75.0%) |
Mar 1994 | - | $2.00 M(+81.8%) |
Dec 1993 | - | $1.10 M(-8.3%) |
Sep 1993 | - | $1.20 M(-7.7%) |
Jun 1993 | $1.30 M(+160.0%) | $1.30 M(+160.0%) |
Mar 1993 | - | $500.00 K(0.0%) |
Dec 1992 | - | $500.00 K(0.0%) |
Sep 1992 | - | $500.00 K(0.0%) |
Jun 1992 | $500.00 K(-16.7%) | $500.00 K(-16.7%) |
Mar 1992 | - | $600.00 K(-14.3%) |
Sep 1991 | - | $700.00 K(+16.7%) |
Jun 1991 | $600.00 K(-14.3%) | $600.00 K(0.0%) |
Mar 1991 | - | $600.00 K(-14.3%) |
Dec 1990 | - | $700.00 K(-12.5%) |
Sep 1990 | - | $800.00 K(+14.3%) |
Jun 1990 | $700.00 K(-12.5%) | $700.00 K(-12.5%) |
Mar 1990 | - | $800.00 K(0.0%) |
Sep 1989 | - | $800.00 K(0.0%) |
Jun 1989 | $800.00 K | $800.00 K |
FAQ
- What is ImmunoGen annual total long term liabilities?
- What is the all time high annual total long term liabilities for ImmunoGen?
- What is ImmunoGen annual total long term liabilities year-on-year change?
- What is ImmunoGen quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for ImmunoGen?
- What is ImmunoGen quarterly long term liabilities year-on-year change?
What is ImmunoGen annual total long term liabilities?
The current annual total long term liabilities of IMGN is $71.25 M
What is the all time high annual total long term liabilities for ImmunoGen?
ImmunoGen all-time high annual total long term liabilities is $301.11 M
What is ImmunoGen annual total long term liabilities year-on-year change?
Over the past year, IMGN annual total long term liabilities has changed by -$27.98 M (-28.20%)
What is ImmunoGen quarterly total long term liabilities?
The current quarterly long term liabilities of IMGN is $125.84 M
What is the all time high quarterly long term liabilities for ImmunoGen?
ImmunoGen all-time high quarterly total long term liabilities is $301.11 M
What is ImmunoGen quarterly long term liabilities year-on-year change?
Over the past year, IMGN quarterly total long term liabilities has changed by +$48.70 M (+63.12%)